Ultrasound Marker Assessment for Nuchal Translucency: Trisomy 21 Early Detection and its application in C++ Programming,Used

Ultrasound Marker Assessment for Nuchal Translucency: Trisomy 21 Early Detection and its application in C++ Programming,Used

In Stock
SKU: DADAX3845432217
Brand: LAP Lambert Academic Publishing
$88.61 $126.59
Save $37.98
Quantity
Add to wishlist
Add to compare

Processing time: 1-3 days

US Orders Ships in: 3-5 days

International Orders Ships in: 8-12 days

Return Policy: 15-days return on defective items

Payment Option
Payment Methods

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

Prenatal diagnosis of fetal abnormities including measurement of Nuchal Translucency (NT) using ultrasonography is widely practiced during early pregnancy. The drawback of current NT measurement technique is restricted with inter and intraobserver variability and inconsistency of results. This book, therefore, proposes an automated detection and measurement method for NT thickness. Artificial neural network was trained to locate the preferable region that contains NT. Border detection of NT based on Dynamic Programming algorithm is utilized to find the optimal thickness of the windowed region. Risk calculation is developed referring to deltaNT via maternal age and NT thickness. The system is designed and implemented using C++ programming environment. This should be especially useful for students, lecturers or professional researchers in biomedical and image processing fields.

⚠️ WARNING (California Proposition 65):

This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.

For more information, please visit www.P65Warnings.ca.gov.

Recently Viewed